Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BREAK BIOFILMS

Financiado

Breaking Bad Biofilms. Innovative Analysis and Design Rules for Next Generation...

Breaking Bad Biofilms. Innovative Analysis and Design Rules for Next Generation Antifouling Interfaces Biofilms, i.e. communities of micro-organisms that attach and grow on a solid surface, cause about 80% of infections in humans and disinfectants rarely succeed in destroying them. They cost European economy billions of euro annual... ver más

30/04/2023

UNIOVI

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

Universidad de Oviedo No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 787

Ver 17 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-04-30

MSCA-ITN-2018: Innovative Training Networks

I+D

Cerrada hace 6 años

0% 100% 100%

17 Participantes

UNIOVI

501.81K€ | Lider

PROCESAMIENTO DIGITAL Y SIST...

290.25K€ | Participante

UNIBA

523.00K€ | Participante

DUPONT

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

MOBILE Investigating microbial colonization and removal on dynamic... 173K€ Cerrado

PCI2022-132923 NANO-ENABLED STIMULI-RESPONSIVE SCAFFOLDS FOR TARGETED ANTIM... 250K€ Cerrado

TEC2009-14779-C02-02 DESARROLLO DE UNA PLATAFORMA PARA MONITORIZACION SISTEMATICA... 116K€ Cerrado

RTI2018-099019-A-I00 DESARROLLO DE TECNOLOGIAS DE FLUJO CONTINUO BASADAS EN SISTE... 128K€ Cerrado

PCI2021-121926 NANOENABLED STRATEGIES TO REDUCE THE PRESENCE OF CONTAMINANT... 200K€ Cerrado

EIN2020-112327 NANOPARTICULAS PUNZANTES BASADAS EN CELULOSA COMO BACTERICID... 15K€ Cerrado

Duración del proyecto: 56 meses Fecha Inicio: 2018-08-20
Fecha Fin: 2023-04-30

Líder del proyecto

Universidad de Oviedo No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 787

Presupuesto del proyecto 4M€

Descripción del proyecto Biofilms, i.e. communities of micro-organisms that attach and grow on a solid surface, cause about 80% of infections in humans and disinfectants rarely succeed in destroying them. They cost European economy billions of euro annually. The BREAK BIOFILMS Training Network aims to solve this issue by training the next generation leaders. They will understand the (bio)physicochemical mechanisms of biofilm formation, be able to produce technology for detecting and identifying biofilm formation with extreme sensitivity, and develop next generation biocides for preventing and destroying biofilms in industrial and biomedical areas. This integrated strategy from biofilm detection to destruction that builds on key innovations from the partner labs, is globally distinctive and promises significant progress. The network brings together world leaders in sensors, cell imaging, microbiology, interfacial engineering and nanoformulation from 6 universities, 9 companies, a research centre, and a Business and Innovation Centre. Thus, it is ideal to provide technical, industrial and business training to 15 ESRs and support the missions of the industry partners who will provide deep insights into the most pressing and impactful challenges. The graduates will be ideally placed to enter and support existing European industry across a number of different sectors (biomedical, food, antimicrobials). However, they will also be capable of creating new businesses thanks to a combination of in depth training in entrepreneurship and direct experience of establishing and running a virtual company as part of the training network. Beyond the trained researchers, this project will produce technologies that will enhance the productivity of European industry, create intellectual property with a strong probability of commercialization and improve the health and well-being of European citizens by minimizing infection rates and the inappropriate use of ineffective biocides that is leading to resistance.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores